help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maile, L. A.
Right arrow Articles by Clemmons, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maile, L. A.
Right arrow Articles by Clemmons, D. R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
*Genetics Home Reference
Endocrinology Vol. 143, No. 11 4259-4264
Copyright © 2002 by The Endocrine Society

ARTICLE

The {alpha}Vß3 Integrin Regulates Insulin-Like Growth Factor I (IGF-I) Receptor Phosphorylation by Altering the Rate of Recruitment of the Src-Homology 2-Containing Phosphotyrosine Phosphatase-2 to the Activated IGF-I Receptor

Laura A. Maile and David R. Clemmons

University of North Carolina Department of Medicine, Division of Endocrinology and Metabolism, Chapel Hill, North Carolina 27599-7170

Address all correspondence and requests for reprints to: David R. Clemmons, M.D, CB 7170, 6111 Thurston-Bowles, Division of Endocrinology, University of North Carolina, Chapel Hill, North Carolina 27599-7170. E-mail: endo{at}med.unc.edu.

The {alpha}Vß3 integrin is an important determinant of IGF-I-stimulated receptor phosphorylation and biological actions. Blocking ligand occupancy of {alpha}Vß3 with the distintegrin echistatin reduces IGF-I-stimulated receptor phosphorylation, and it inhibits cellular migration and DNA synthesis responses to IGF-I. We have shown that recruitment of the tyrosine phosphatase Src-homology 2-containing phosphotyrosine phosphatase-2 (SHP-2) to the IGF-I receptor (IGF-IR) is an important determinant of the duration of IGF-IR phosphorylation. These studies were undertaken to determine whether an alteration in the recruitment of SHP-2 to the receptor in the presence of echistatin could account for the decrease in receptor phosphorylation. Following an overnight exposure of smooth muscle cell cultures to echistatin, the addition of IGF-I was accompanied by rapid dephosphorylation of IGF-IR compared with cells exposed to media alone. This was associated with an increase in the rate of SHP-2 recruitment to the IGF-IR. In cells expressing a catalytically inactive form of SHP-2, prior exposure to echistatin had no effect on the rate of receptor dephosphorylation. In contrast to the usual physiologic situation in which following IGF-I exposure SHP-2 is recruited to IGF-IR via SHP-2 substrate-1 (SHPS-1) in the presence of echistatin, SHPS-1 was not used for SHP-2 recruitment. Our findings show that IRS-1 may substitute for SHPS-1 under these conditions. These results demonstrate that the activation state of {alpha}Vß3 is an important regulator of the duration of IGF-IR phosphorylation and subsequent downstream signaling and that this regulation is mediated through changes in the subcellular localization of SHP-2.




This article has been cited by other articles:


Home page
 EndocrinologyHome page
S. Perrini, A. Natalicchio, L. Laviola, A. Cignarelli, M. Melchiorre, F. De Stefano, C. Caccioppoli, A. Leonardini, S. Martemucci, G. Belsanti, et al.
Abnormalities of Insulin-Like Growth Factor-I Signaling and Impaired Cell Proliferation in Osteoblasts from Subjects with Osteoporosis
Endocrinology, March 1, 2008; 149(3): 1302 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Edderkaoui, P. Hong, J. K. Lee, S. J. Pandol, and A. S. Gukovskaya
Insulin-like Growth Factor-I Receptor Mediates the Prosurvival Effect of Fibronectin
J. Biol. Chem., September 14, 2007; 282(37): 26646 - 26655.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Endocr. Rev., February 1, 2007; 28(1): 20 - 47.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Lieskovska, Y. Ling, J. Badley-Clarke, and D. R. Clemmons
The Role of Src Kinase in Insulin-like Growth Factor-dependent Mitogenic Signaling in Vascular Smooth Muscle Cells
J. Biol. Chem., September 1, 2006; 281(35): 25041 - 25053.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle
Occupation of {alpha}vbeta3-integrin by endogenous ligands modulates IGF-I receptor activation and proliferation of human intestinal smooth muscle
Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1194 - G1202.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M.-R. Shen, Y.-M. Hsu, K.-F. Hsu, Y.-F. Chen, M.-J. Tang, and C.-Y. Chou
Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by {alpha}v{beta}3 integrin signaling
Carcinogenesis, May 1, 2006; 27(5): 962 - 971.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
L. A. Maile, W. H. Busby, K. Sitko, B. E. Capps, T. Sergent, J. Badley-Clarke, Y. Ling, and D. R. Clemmons
The Heparin Binding Domain of Vitronectin Is the Region that Is Required to Enhance Insulin-Like Growth Factor-I Signaling
Mol. Endocrinol., April 1, 2006; 20(4): 881 - 892.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Kwon, Y. Ling, L. A. Maile, J. Badley-Clark, and D. R. Clemmons
Recruitment of the Tyrosine Phosphatase Src Homology 2 Domain Tyrosine Phosphatase-2 to the p85 Subunit of Phosphatidylinositol-3 (PI-3) Kinase Is Required for Insulin-Like Growth Factor-I-Dependent PI-3 Kinase Activation in Smooth Muscle Cells
Endocrinology, March 1, 2006; 147(3): 1458 - 1465.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
X. X. Wang and K. H. Pfenninger
Functional analysis of SIRP{alpha} in the growth cone
J. Cell Sci., January 1, 2006; 119(1): 172 - 183.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. V. Ferreira, S. A. L. Souza, I. J. P. Arnhold, B. B. Mendonca, and A. A. L. Jorge
PTPN11 (Protein Tyrosine Phosphatase, Nonreceptor Type 11) Mutations and Response to Growth Hormone Therapy in Children with Noonan Syndrome
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5156 - 5160.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Kapur, S. Mohan, D. J. Baylink, and K.-H. W. Lau
Fluid Shear Stress Synergizes with Insulin-like Growth Factor-I (IGF-I) on Osteoblast Proliferation through Integrin-dependent Activation of IGF-I Mitogenic Signaling Pathway
J. Biol. Chem., May 20, 2005; 280(20): 20163 - 20170.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. A. Kiely, M. Leahy, D. O'Gorman, and R. O'Connor
RACK1-mediated Integration of Adhesion and Insulin-like Growth Factor I (IGF-I) Signaling and Cell Migration Are Defective in Cells Expressing an IGF-I Receptor Mutated at Tyrosines 1250 and 1251
J. Biol. Chem., March 4, 2005; 280(9): 7624 - 7633.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Ling, L. A. Maile, J. Badley-Clarke, and D. R. Clemmons
DOK1 Mediates SHP-2 Binding to the {alpha}V{beta}3 Integrin and Thereby Regulates Insulin-like Growth Factor I Signaling in Cultured Vascular Smooth Muscle Cells
J. Biol. Chem., February 4, 2005; 280(5): 3151 - 3158.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. R. Clemmons and L. A. Maile
Interaction between Insulin-Like Growth Factor-I Receptor and {alpha}V{beta}3 Integrin Linked Signaling Pathways: Cellular Responses to Changes in Multiple Signaling Inputs
Mol. Endocrinol., January 1, 2005; 19(1): 1 - 11.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. J. Pereira, T. Meyer, S. E. Docherty, H. H. Reid, J. Marshall, E. W. Thompson, J. Rossjohn, and J. T. Price
Bimolecular Interaction of Insulin-Like Growth Factor (IGF) Binding Protein-2 with {alpha}v{beta}3 Negatively Modulates IGF-I-Mediated Migration and Tumor Growth1
Cancer Res., February 1, 2004; 64(3): 977 - 984.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
L. A. Maile and D. R. Clemmons
Integrin-Associated Protein Binding Domain of Thrombospondin-1 Enhances Insulin-Like Growth Factor-I Receptor Signaling in Vascular Smooth Muscle Cells
Circ. Res., November 14, 2003; 93(10): 925 - 931.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Y. Ling, L. A. Maile, and D. R. Clemmons
Tyrosine Phosphorylation of the {beta}3-Subunit of the {alpha}V{beta}3 Integrin Is Required for Membrane Association of the Tyrosine Phosphatase SHP-2 and Its Further Recruitment to the Insulin-Like Growth Factor I Receptor
Mol. Endocrinol., September 1, 2003; 17(9): 1824 - 1833.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
L. A. Maile, J. Badley-Clarke, and D. R. Clemmons
The Association between Integrin-associated Protein and SHPS-1 Regulates Insulin-like Growth Factor-I Receptor Signaling in Vascular Smooth Muscle Cells
Mol. Biol. Cell, September 1, 2003; 14(9): 3519 - 3528.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. R. Clemmons and L. A. Maile
Minireview: Integral Membrane Proteins that Function Coordinately with the Insulin-Like Growth Factor I Receptor to Regulate Intracellular Signaling
Endocrinology, May 1, 2003; 144(5): 1664 - 1670.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Kabir-Salmani, S. Shiokawa, Y. Akimoto, K. Sakai, S. Nagamatsu, K. Sakai, Y. Nakamura, A. Lotfi, H. Kawakami, and M. Iwashita
{alpha}v{beta}3 Integrin Signaling Pathway Is Involved in Insulin-Like Growth Factor I-Stimulated Human Extravillous Trophoblast Cell Migration
Endocrinology, April 1, 2003; 144(4): 1620 - 1630.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society